SFTPA1 and metabolic dysfunction-associated steatotic liver disease: In addition, the upregulation of inflammatory mediators in WT mice fed W-D but downregulated in SPA-deficient mice further implies that SPA may promote liver inflammation to exacerbate the pathogenesis of MASLD.